Progen Co., Ltd. (XKON:296160)
South Korea · Delayed Price · Currency is KRW 6,950.00
+500.00 (7.75%)
At close: Jan 28, 2026
Progen Market Cap
Progen has a market cap or net worth of 99.17 billion as of January 29, 2026. Its market cap has increased by 7.56% in one year.
Market Cap
99.17B
Enterprise Value
n/a
Revenue
450.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
6,950.00
Market Cap Chart
Since November 15, 2023, Progen's market cap has increased from 46.33B to 99.17B, an increase of 114.08%. That is a compound annual growth rate of 41.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 99.17B | -7.96% |
| Dec 30, 2025 | 107.75B | 19.24% |
| Dec 30, 2024 | 90.36B | 9.39% |
| Dec 28, 2023 | 82.60B | 78.30% |
| Nov 15, 2023 | 46.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Parataxis Korea | 123.58B |
| TegoScience | 120.42B |
| KoBioLabs | 114.57B |
| CTCBIO | 106.87B |
| IMGT Co.,Ltd. | 97.41B |
| Cell Biotech | 90.68B |
| Choong Ang Vaccine Laboratory | 90.33B |
| Naturalendo Tech | 90.30B |